FI68627C - Foerfarande foer framstaellning av en koordinationsfoerening av platina i vaesentligen ren form - Google Patents
Foerfarande foer framstaellning av en koordinationsfoerening av platina i vaesentligen ren form Download PDFInfo
- Publication number
- FI68627C FI68627C FI812696A FI812696A FI68627C FI 68627 C FI68627 C FI 68627C FI 812696 A FI812696 A FI 812696A FI 812696 A FI812696 A FI 812696A FI 68627 C FI68627 C FI 68627C
- Authority
- FI
- Finland
- Prior art keywords
- dimethylacetamide
- adduct
- hydrogen peroxide
- platinum
- cis
- Prior art date
Links
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 42
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 23
- 150000001875 compounds Chemical class 0.000 claims description 20
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 17
- 229910052697 platinum Inorganic materials 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 5
- DOYLBWHHKGKDBV-UHFFFAOYSA-N platinum(2+);propan-2-amine Chemical compound [Pt+2].CC(C)N DOYLBWHHKGKDBV-UHFFFAOYSA-N 0.000 claims description 3
- AJWDBMRAQLRSCK-UHFFFAOYSA-N platinum;propan-2-amine Chemical compound [Pt].CC(C)N AJWDBMRAQLRSCK-UHFFFAOYSA-N 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- DXPWSKZZCVZLSD-UHFFFAOYSA-N platinum(4+) propan-2-amine Chemical compound [Pt+4].CC(C)N DXPWSKZZCVZLSD-UHFFFAOYSA-N 0.000 claims 1
- 238000002360 preparation method Methods 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 238000002329 infrared spectrum Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000012043 crude product Substances 0.000 description 4
- 150000004820 halides Chemical class 0.000 description 4
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 4
- 125000002577 pseudohalo group Chemical group 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 3
- 150000001540 azides Chemical class 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 150000001805 chlorine compounds Chemical class 0.000 description 3
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical group OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 3
- 238000000634 powder X-ray diffraction Methods 0.000 description 3
- KDSNLYIMUZNERS-UHFFFAOYSA-N 2-methylpropanamine Chemical compound CC(C)CN KDSNLYIMUZNERS-UHFFFAOYSA-N 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 125000002877 alkyl aryl group Chemical group 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- XLJMAIOERFSOGZ-UHFFFAOYSA-M cyanate Chemical compound [O-]C#N XLJMAIOERFSOGZ-UHFFFAOYSA-M 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 150000002367 halogens Chemical group 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- -1 hydroxy, carbonyl Chemical group 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- BMFVGAAISNGQNM-UHFFFAOYSA-N isopentylamine Chemical compound CC(C)CCN BMFVGAAISNGQNM-UHFFFAOYSA-N 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 230000036210 malignancy Effects 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 150000003460 sulfonic acids Chemical group 0.000 description 2
- 238000002411 thermogravimetry Methods 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical group OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- BSSGROOCGJWOIR-UHFFFAOYSA-N [C-]#N.N#CO Chemical compound [C-]#N.N#CO BSSGROOCGJWOIR-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 150000001734 carboxylic acid salts Chemical group 0.000 description 1
- 150000001735 carboxylic acids Chemical group 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 229940125846 compound 25 Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000001030 gas--liquid chromatography Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- WGBBUURBHXLGFM-UHFFFAOYSA-N hexan-2-amine Chemical compound CCCCC(C)N WGBBUURBHXLGFM-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- NDBYXKQCPYUOMI-UHFFFAOYSA-N platinum(4+) Chemical compound [Pt+4] NDBYXKQCPYUOMI-UHFFFAOYSA-N 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8028484 | 1980-09-03 | ||
| GB8028484 | 1980-09-03 | ||
| GB8115549 | 1981-05-20 | ||
| GB8115549 | 1981-05-20 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI812696L FI812696L (fi) | 1982-03-04 |
| FI68627B FI68627B (fi) | 1985-06-28 |
| FI68627C true FI68627C (fi) | 1985-10-10 |
Family
ID=26276771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI812696A FI68627C (fi) | 1980-09-03 | 1981-09-01 | Foerfarande foer framstaellning av en koordinationsfoerening av platina i vaesentligen ren form |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US4394319A (nl) |
| AT (1) | AT375626B (nl) |
| AU (1) | AU541255B2 (nl) |
| CA (1) | CA1176646A (nl) |
| CH (1) | CH651840A5 (nl) |
| CS (1) | CS229919B2 (nl) |
| CY (1) | CY1384A (nl) |
| DE (1) | DE3134671C2 (nl) |
| DK (2) | DK150474C (nl) |
| ES (1) | ES505090A0 (nl) |
| FI (1) | FI68627C (nl) |
| FR (1) | FR2489314A1 (nl) |
| GB (1) | GB2085440B (nl) |
| GR (1) | GR75317B (nl) |
| HK (1) | HK97087A (nl) |
| HU (1) | HU185951B (nl) |
| IE (1) | IE51539B1 (nl) |
| IL (1) | IL63658A0 (nl) |
| IT (1) | IT1194090B (nl) |
| KE (1) | KE3729A (nl) |
| LU (1) | LU83599A1 (nl) |
| MY (1) | MY8700553A (nl) |
| NL (1) | NL190326C (nl) |
| PH (1) | PH22094A (nl) |
| SE (1) | SE452467B (nl) |
| SG (1) | SG42787G (nl) |
| WO (1) | WO1982000825A1 (nl) |
| YU (1) | YU42726B (nl) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3305248C2 (de) * | 1983-02-16 | 1987-04-09 | Degussa Ag, 6000 Frankfurt | Verfahren zur Reinigung von cis-Platin-(II)-diammin-dichlorid |
| GB8328218D0 (en) * | 1983-10-21 | 1983-11-23 | Johnson Matthey Plc | Oral compositions |
| US4772735A (en) * | 1986-08-25 | 1988-09-20 | University Of Delaware | Coordination complexes of platinum with amides |
| CA1339034C (en) * | 1988-08-22 | 1997-04-01 | Paul A. Tremblay | Platinum complexes of single isomer neoalkyl acids |
| GB9105037D0 (en) * | 1991-03-09 | 1991-04-24 | Johnson Matthey Plc | Improvements in chemical compounds |
| EP2266607A3 (en) | 1999-10-01 | 2011-04-20 | Immunogen, Inc. | Immunoconjugates for treating cancer |
| GB0011903D0 (en) * | 2000-05-18 | 2000-07-05 | Astrazeneca Ab | Combination chemotherapy |
| US6492312B1 (en) | 2001-03-16 | 2002-12-10 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Water soluble sachet with a dishwashing enhancing particle |
| ATE346076T1 (de) * | 2003-10-13 | 2006-12-15 | Salama Zoser B Nat Rer Dr | Verfahren zur herstellung von trans- oder cis- diammoniumdichlorodihydroxoplatin (iv)-salzen und derivaten und ihre verwendung zur herstellung von pharmazeutischen wirkstoffen |
| US8173686B2 (en) | 2006-11-06 | 2012-05-08 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8178564B2 (en) * | 2006-11-06 | 2012-05-15 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8168662B1 (en) | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8168661B2 (en) * | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US20110033528A1 (en) * | 2009-08-05 | 2011-02-10 | Poniard Pharmaceuticals, Inc. | Stabilized picoplatin oral dosage form |
| TW200916094A (en) * | 2007-06-27 | 2009-04-16 | Poniard Pharmaceuticals Inc | Stabilized picoplatin dosage form |
| US20100260832A1 (en) * | 2007-06-27 | 2010-10-14 | Poniard Pharmaceuticals, Inc. | Combination therapy for ovarian cancer |
| JP2010533714A (ja) * | 2007-07-16 | 2010-10-28 | ポニアード ファーマシューティカルズ， インコーポレイテッド | ピコプラチンのための経口製剤 |
| US10316050B2 (en) | 2014-08-13 | 2019-06-11 | The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas | PT (IV) complexes containing 4,4′-disubstituted-2,2′-bipyridyl and their use in cancer therapy |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1578323A (en) * | 1976-02-26 | 1980-11-05 | Rustenburg Platinum Mines Ltd | Compositions containing platinum |
| SE7903359L (sv) * | 1978-04-20 | 1979-10-21 | Johnson Matthey Co Ltd | Kompositioner innehallande platina |
-
1981
- 1981-08-25 IL IL63658A patent/IL63658A0/xx not_active IP Right Cessation
- 1981-08-25 GR GR65868A patent/GR75317B/el unknown
- 1981-08-26 US US06/296,478 patent/US4394319A/en not_active Expired - Fee Related
- 1981-08-26 NL NLAANVRAGE8103954,A patent/NL190326C/nl not_active IP Right Cessation
- 1981-08-28 AU AU74725/81A patent/AU541255B2/en not_active Ceased
- 1981-09-01 ES ES505090A patent/ES505090A0/es active Granted
- 1981-09-01 FI FI812696A patent/FI68627C/fi not_active IP Right Cessation
- 1981-09-02 IE IE2027/81A patent/IE51539B1/en not_active IP Right Cessation
- 1981-09-02 FR FR8116703A patent/FR2489314A1/fr active Granted
- 1981-09-02 HU HU812536A patent/HU185951B/hu not_active IP Right Cessation
- 1981-09-02 DE DE3134671A patent/DE3134671C2/de not_active Expired - Fee Related
- 1981-09-02 SE SE8105213A patent/SE452467B/sv not_active IP Right Cessation
- 1981-09-02 LU LU83599A patent/LU83599A1/fr unknown
- 1981-09-02 AT AT0379081A patent/AT375626B/de not_active IP Right Cessation
- 1981-09-02 DK DK388281A patent/DK150474C/da not_active IP Right Cessation
- 1981-09-02 CA CA000385038A patent/CA1176646A/en not_active Expired
- 1981-09-03 CH CH5676/81A patent/CH651840A5/fr not_active IP Right Cessation
- 1981-09-03 YU YU2119/81A patent/YU42726B/xx unknown
- 1981-09-03 WO PCT/GB1981/000177 patent/WO1982000825A1/en unknown
- 1981-09-03 CS CS816539A patent/CS229919B2/cs unknown
- 1981-09-03 CY CY138481A patent/CY1384A/xx unknown
- 1981-09-03 GB GB8126659A patent/GB2085440B/en not_active Expired
- 1981-09-03 IT IT23756/81A patent/IT1194090B/it active
- 1981-09-04 PH PH26144A patent/PH22094A/en unknown
-
1986
- 1986-07-11 DK DK330086A patent/DK154068C/da not_active IP Right Cessation
-
1987
- 1987-05-08 SG SG42787A patent/SG42787G/en unknown
- 1987-05-18 KE KE3729A patent/KE3729A/xx unknown
- 1987-12-17 HK HK970/87A patent/HK97087A/xx unknown
- 1987-12-30 MY MY553/87A patent/MY8700553A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI68627C (fi) | Foerfarande foer framstaellning av en koordinationsfoerening av platina i vaesentligen ren form | |
| US4921984A (en) | Novel platinum complexes | |
| JP3997232B2 (ja) | １，２−ジアミノシクロヘキサン−白金（ｉｉ）−錯体の製造方法 | |
| US4119653A (en) | Co-ordination compounds of platinum | |
| US7208616B2 (en) | Cis-diiodo-(trans-L-1,2-cyclohexanediamine) platinum (II) complex and processes for preparing high purity oxaliplatin | |
| ES2320554T3 (es) | Oxaliplatino con un bajo contenido de impurezas acompañantes y un metodo para su preparacion. | |
| US6197998B1 (en) | Process for producing N-glycyltyrosine and its crystal structure | |
| EP2855496A1 (en) | Synthetic and purification methods for phosphaplatin compounds and uses thereof | |
| IL139528A (en) | Platinum bracelets, processes for their preparation and pharmaceutical preparations containing them | |
| US4182724A (en) | Compositions containing platinum | |
| EP2243773B1 (en) | Platinum complex compound and utilization of the same | |
| Bottomley et al. | Electrophilic nitrosyls: preparation, structure, and reactivity of cis-chloronitrosylbis (pyridine-2-carboxylato) ruthenium and related complexes | |
| JPS5824569A (ja) | イミダゾ−ル誘導体の精製方法 | |
| KR20030022262A (ko) | 살렌 화합물의 망간 착물의 제조방법 | |
| Kukushkin et al. | Dehydrohalogenation and dimeric complex formation proceeded at the solid-phase heating of trans-[Pt (3-methyl-4-acetyl-5-aminopyrazole)(dimethyl sulphoxide) Cl2]. X-ray structure of the DI-μ-N1, N2-(3-methyl-4-acetyl-5-aminopyrazolate) bis (dimethyl sulphoxide) dichlorodiplatinum (II) | |
| JPH0349916B2 (nl) | ||
| Czauderna et al. | Trifluoromethylphenyl Palladium (II) Complexes–Synthesis and Characterization | |
| Yashiro et al. | Efficient stereochemical regulation of octahedral cobalt (III) complexes by a chiral bidentate ligand. Part 2. Remarkable effect of the chelate-ring size in the stereoselective formation of sym-cis-(ethylenediamine-N, N′-diacetato)(pentane-2, 4-diamine) cobalt (III) | |
| Mønsted et al. | lridium (Ill) Complexes of Macrocyclic Ligands. Preparation and Characterization of Iridium (Ill) Complexes of | |
| CN116332964A (zh) | 一种双齿吡唑基氮杂环钯卡宾化合物的合成方法 | |
| KR100228919B1 (ko) | 벤조페논유도체의 제조방법 | |
| Pagani | Cyclic sulphones. Part XVI. Probes for conjugation of the sulphonyl group: thiopyranylidenedihydropyridine SS-dioxides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: JOHNSON MATTHEY PUBLIC LIMITED COMPANY |